ATE2699T1 - Serologisches verfahren zum nachweis von neisseria gonorrhoeae antikoerpern im menschlichen serum, ein dazu angewendetes speziesspezifisches waermestabiles antigen und verfahren zur herstellung dieses antigens. - Google Patents

Serologisches verfahren zum nachweis von neisseria gonorrhoeae antikoerpern im menschlichen serum, ein dazu angewendetes speziesspezifisches waermestabiles antigen und verfahren zur herstellung dieses antigens.

Info

Publication number
ATE2699T1
ATE2699T1 AT79101430T AT79101430T ATE2699T1 AT E2699 T1 ATE2699 T1 AT E2699T1 AT 79101430 T AT79101430 T AT 79101430T AT 79101430 T AT79101430 T AT 79101430T AT E2699 T1 ATE2699 T1 AT E2699T1
Authority
AT
Austria
Prior art keywords
antigen
detection
production
neisseria gonorrhoeae
human serum
Prior art date
Application number
AT79101430T
Other languages
English (en)
Inventor
Hassan A. Gaafar
Original Assignee
Research Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corporation filed Critical Research Corporation
Application granted granted Critical
Publication of ATE2699T1 publication Critical patent/ATE2699T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/12—Nitrate to nitrite reducing bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT79101430T 1978-05-15 1979-05-10 Serologisches verfahren zum nachweis von neisseria gonorrhoeae antikoerpern im menschlichen serum, ein dazu angewendetes speziesspezifisches waermestabiles antigen und verfahren zur herstellung dieses antigens. ATE2699T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/905,954 US4241045A (en) 1978-05-15 1978-05-15 Purified antigen to test for Neisseria gonorrheae antibodies
EP79101430A EP0005512B1 (de) 1978-05-15 1979-05-10 Serologisches Verfahren zum Nachweis von Neisseria gonorrhoeae Antikörpern im menschlichen Serum, ein dazu angewendetes speziesspezifisches wärmestabiles Antigen und Verfahren zur Herstellung dieses Antigens

Publications (1)

Publication Number Publication Date
ATE2699T1 true ATE2699T1 (de) 1983-03-15

Family

ID=25421734

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79101430T ATE2699T1 (de) 1978-05-15 1979-05-10 Serologisches verfahren zum nachweis von neisseria gonorrhoeae antikoerpern im menschlichen serum, ein dazu angewendetes speziesspezifisches waermestabiles antigen und verfahren zur herstellung dieses antigens.

Country Status (9)

Country Link
US (1) US4241045A (de)
EP (1) EP0005512B1 (de)
JP (1) JPS5516290A (de)
AT (1) ATE2699T1 (de)
AU (1) AU525403B2 (de)
CA (1) CA1121723A (de)
DE (1) DE2964944D1 (de)
DK (1) DK199779A (de)
ES (1) ES480474A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351761A (en) * 1978-05-15 1982-09-28 Research Corporation Purified antigen to test for Neisseria gonorrhoeae antibodies
US4497899A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Chlamydia trachomatis antigens
US4497900A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Neisseria gonorrhoeae antigens
WO1985004654A1 (en) * 1984-04-06 1985-10-24 Scripps Clinic And Research Foundation A peptide vaccine or diagnostic, and a polypeptide useful therefor
EP0216841A1 (de) * 1985-03-18 1987-04-08 Btg International Limited Antigenaktives protein und seine anwendung zur diagnose von gonorrhoea
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
ATE82397T1 (de) * 1987-08-13 1992-11-15 Synbiotics Corp Bestimmungen einer amphipathischen substanz durch verwendung einer lipophilen oberflaeche.
US5851527A (en) * 1988-04-18 1998-12-22 Immunomedics, Inc. Method for antibody targeting of therapeutic agents
DE68918189T2 (de) 1988-06-29 1995-01-12 Univ Rockefeller Neisseria-Vakzine.
US5032504A (en) * 1988-10-07 1991-07-16 Eastman Kodak Company Diagnostic test kit and method for determination of chlamydial or gonococcal antigens using a microporous membrane
US5234817A (en) * 1988-10-07 1993-08-10 Eastman Kodak Company Wash solution containing a cationic surfactant and its use in chlamydial and gonococcal determinations
US5075220A (en) * 1988-10-07 1991-12-24 Eastman Kodak Company Determination of a chlamydial or gonococcal antigen using a positively-charged ionically binding support
US5047325A (en) * 1988-10-07 1991-09-10 Eastman Kodak Company Wash solution containing a cationic surfactant and its use in chlamydial and gonococcal determinations
US5089389A (en) * 1989-08-25 1992-02-18 Eastman Kodak Company Buffered composition, coated article test device and a method for their use
IL107628A0 (en) * 1992-11-18 1994-02-27 Calypte Inc Immunoassays for microorganisms associated with sexually transmitted diseases
WO2008153674A1 (en) * 2007-06-09 2008-12-18 Boris Kobrin Method and apparatus for anisotropic etching

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1378103A (en) * 1972-08-31 1974-12-18 Research Corp Serological reagent and test for neisseria gonorrhoeae antibodies
CA1045031A (en) * 1973-04-04 1978-12-26 Akzona Incorporated Serological test for gonorrheal antibodies
GB1549345A (en) * 1975-04-25 1979-08-08 Bactex Inc Gonococcal pili processes for the preparation thereof and the use thereof
US4029756A (en) * 1975-11-26 1977-06-14 Research Corporation Serological procedure for determining presence of neisseria gonorrhoeae antibodies
GB1560570A (en) * 1976-01-29 1980-02-06 Fisher Scientific Co Method of obtaining and using antigen from neisseria gonorrheae and products prepared therefrom
CA1083956A (en) * 1976-10-12 1980-08-19 Susan M. Mondabaugh Microbial antibodies immunoassay
US4115543A (en) * 1976-12-20 1978-09-19 Canadian Patents & Development Limited Identification of Neisseria gonorrhoeae
US4140581A (en) * 1977-09-28 1979-02-20 Corning Glass Works Immunoassay of Neisseria bacteria via (NH4)2 SO4 precipitation

Also Published As

Publication number Publication date
CA1121723A (en) 1982-04-13
EP0005512A3 (en) 1980-05-14
JPS5516290A (en) 1980-02-04
AU525403B2 (en) 1982-11-04
DK199779A (da) 1979-11-16
DE2964944D1 (en) 1983-04-07
AU4695479A (en) 1979-11-22
EP0005512B1 (de) 1983-03-02
EP0005512A2 (de) 1979-11-28
ES480474A1 (es) 1980-04-01
US4241045A (en) 1980-12-23

Similar Documents

Publication Publication Date Title
ATE2699T1 (de) Serologisches verfahren zum nachweis von neisseria gonorrhoeae antikoerpern im menschlichen serum, ein dazu angewendetes speziesspezifisches waermestabiles antigen und verfahren zur herstellung dieses antigens.
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
GB1436934A (en) Method of testing blood
DE68923882D1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
DE3577233D1 (de) Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem human-prothrombin.
DE2963773D1 (en) Immunological determination process
ATE15945T1 (de) Verfahren zum nachweis von haemoglobin in faezes.
ATE118275T1 (de) Immunoassayverfahren zum nachweis von antigenen.
DE3587268D1 (de) Verfahren zur isolierung des mycobakteriellen antigens-a60 und die verwendung dieses antigens zur herstellung von immunologischen reagenzien und in immunologischen testverfahren.
ATE75041T1 (de) Verfahren und vorrichtung zur messung des reaktionsgrades zwischen antigenen und zellleukozytenantik¯rpern.
NO881151L (no) Syntetisk hiv-1-antigen.
DE68922842D1 (de) Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper.
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
DE2965570D1 (en) Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination
ES2141348T3 (es) Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo.
DE68922126D1 (de) Immunometrisches Verfahren zum Nachweis von Lipoprotein-Teilchen, anti-Lp(a) Monoklonale Antikörper und ihre Anwendung zur Diagnose von Atherosklerose.
DE3686717D1 (de) Immuntestverfahren.
JPS6488369A (en) Method of detecting and verifying presence of antibody
EP0266686A3 (en) Latex agglutination method for the detection of an antibody against streptococcus deoxyribonuclease b
DE69132053D1 (de) Verfahren zur prüfung für salmonella
ATE60445T1 (de) Verfahren und testelement zum auffinden von zellaesionen.
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
ATE132896T1 (de) Methoden zur verwendung von an humanen klasse-ii- histokompatibilitätsantigenen mangelnden zellinien
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
SE8603312D0 (sv) Sett att overvaka fermentering

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee